SCHEMBL6175907

SCHEMBL6175907

CC(c1ccncc1NC(=O)Oc1ccccc1)C1(C(C)c2ccncc2NC(=O)Oc2ccccc2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TRPV1 Q8NER1 1/20 0.36
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
GSK3A P49840 1/20 0.35
GSK3B P49841 1/20 0.35
LMNA P02545 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
PDE2A O00408 1/20 0.34
CYP1A2 P05177 1/20 0.33
CXCR3 P49682 1/20 0.33
DGAT2 Q96PD7 1/20 0.33
P2RY2 P41231 1/20 0.33
P2RY1 P47900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174515 0.89 ALDH1A1 (0.45) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6172844 0.89 CYP3A4 (0.40) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6173454 0.88 CYP2C9 (0.41) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6175647 0.88 ALDH1A1 (0.38) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6174412 0.88 MAPT (0.39) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6173573 0.87 CACNA1H (0.41) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6278206 0.87 TRPV1 (0.49) ALDH1A1TRPV1KDM5AKDM4CKDM5B
SCHEMBL6173899 0.87 ALDH1A1 (0.39) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6174469 0.85 TDP1 (0.42) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6173479 0.85 ALDH1A1 (0.44) ALDH1A1CYP3A4GAACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed